Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ketamine 0.5% for Pain During Pan-Retinal Photocoagulation
TCTR20260710019Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in diabetic retinopathy (DR), sponsored by Tehran University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
ketamine
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on TCTR20260710019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260710019.